256 related articles for article (PubMed ID: 3633253)
21. [Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
Loew D; Breddin K; Uberla K
MMW Munch Med Wochenschr; 1982 Jan; 124(1):46-56. PubMed ID: 6120454
[No Abstract] [Full Text] [Related]
22. [Platelet antiaggregants and arteriopathies].
Cristol R
J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714
[No Abstract] [Full Text] [Related]
23. [Thrombosis prevention with thrombocyte aggregation inhibitors in the venous system].
Schöndorf TH
Med Welt; 1982 Jun; 33(23):851-4. PubMed ID: 7050615
[No Abstract] [Full Text] [Related]
24. [Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
Avellone G; Mandalà V; Novo S; Pinto A; Riolo FP; Davì G; Raneli G
Boll Soc Ital Cardiol; 1981; 26(8):697-712. PubMed ID: 6289854
[No Abstract] [Full Text] [Related]
25. [Anti-aggregation therapy of patients with ischemic heart disease].
Liusov VA; Savenkov MP
Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
[No Abstract] [Full Text] [Related]
26. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson JE; Olsson O; Thornberg A
Lakartidningen; 1980 Dec; 77(52):4947-56. PubMed ID: 7010029
[No Abstract] [Full Text] [Related]
27. Aspirin and recurrent myocardial infarction.
Jones RJ
JAMA; 1980 Aug; 244(7):667-8. PubMed ID: 6993715
[No Abstract] [Full Text] [Related]
28. [Inhibitors of platelet aggregation in the therapy of arteriosclerosis obliterans].
Zabel Langhennig R
Z Gesamte Inn Med; 1979 May; 34(10):117-20. PubMed ID: 483916
[TBL] [Abstract][Full Text] [Related]
29. [Treatment and prevention of thromboembolism with anti-aggregation drugs].
Donner L
Vnitr Lek; 1981 May; 27(5):487-95. PubMed ID: 7245635
[No Abstract] [Full Text] [Related]
30. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Bousser MG
Ann Med Interne (Paris); 1983; 134(2):79-83. PubMed ID: 6349464
[No Abstract] [Full Text] [Related]
31. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
Offerhaus L
Ned Tijdschr Geneeskd; 1983 Apr; 127(16):673-9. PubMed ID: 6134240
[No Abstract] [Full Text] [Related]
32. [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Schröder R
Dtsch Med Wochenschr; 1981 Apr; 106(17):546-53. PubMed ID: 6111439
[No Abstract] [Full Text] [Related]
33. Antiplatelet and anticoagulant therapy in acute myocardial infarction.
Jafri SM
Henry Ford Hosp Med J; 1991; 39(3-4):195-9. PubMed ID: 1804824
[No Abstract] [Full Text] [Related]
34. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
35. [Hypercoagulability and cerebral infarction].
Matsuda T
No To Shinkei; 1986 Apr; 38(4):317-27. PubMed ID: 3013261
[No Abstract] [Full Text] [Related]
36. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Hirsh J
Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
[TBL] [Abstract][Full Text] [Related]
37. [Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
Bolte HD
MMW Munch Med Wochenschr; 1980 Apr; 122(14):507-8. PubMed ID: 6769029
[No Abstract] [Full Text] [Related]
38. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
39. [Anti-platelet aggregation therapy and ischaemic cerebral accidents due to atheroma (author's transl)].
Autret A
Nouv Presse Med; 1982 May; 11(20):1543-7. PubMed ID: 7099931
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
